http://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial http://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:4800 Wed 24 Jul 2013 22:22:58 EST ]]>